Lipid MetabolismMarch 18, 20264 min read

Q-Bank Breakdown: Lipoprotein metabolism — Why Every Answer Choice Matters

Clinical vignette on Lipoprotein metabolism. Explain correct answer, then systematically address each distractor. Tag: Biochemistry > Lipid Metabolism.

Q-Bank Breakdown: Lipoprotein Metabolism — Why Every Answer Choice Matters

Tag: Biochemistry > Lipid Metabolism

Lipoprotein questions are classic USMLE traps: the vignette sounds like “high cholesterol,” but the answer depends on which particle, which apolipoprotein, and which enzyme is broken. The fastest way to earn points is to train yourself to explain why the correct choice is correct—and why every distractor is wrong.

Clinical Vignette (USMLE-Style)

A 42-year-old man presents for a routine visit. He has no history of diabetes. Physical exam shows tendon xanthomas and xanthelasmas. His father had a myocardial infarction at age 49. Fasting labs reveal:

  • Total cholesterol: markedly elevated
  • Triglycerides: mildly elevated
  • LDL cholesterol: markedly elevated

Which of the following abnormalities is the most likely cause?

A. Decreased activity of lipoprotein lipase
B. Defective ApoE
C. Decreased LDL receptor function
D. Decreased LCAT activity
E. Increased production of chylomicrons

Step-by-Step: What’s the Diagnosis?

This presentation is most consistent with Familial Hypercholesterolemia (Type IIa):

  • Tendon xanthomas (Achilles, extensor tendons) = high-yield hallmark
  • Premature atherosclerosis/MI
  • Markedly ↑ LDL, triglycerides often normal or mildly increased

✅ Correct Answer: C. Decreased LDL receptor function

Why C Is Correct: Decreased LDL Receptor Function

What the LDL receptor does

The LDL receptor (LDLR) on hepatocytes clears circulating LDL by binding ApoB-100 (and ApoE on remnants).

Pathophysiology (high-yield)

  • LDLR mutation (most common) or ApoB-100 mutation → impaired LDL uptake
  • ↑ LDL in plasma → cholesterol deposition → xanthomas
  • ↑ atherosclerosis risk early

Board-relevant associations

  • Type IIa (Familial hypercholesterolemia): ↑ LDL
  • Tendon xanthomas + premature CAD are the biggest clue
  • Treatment concepts: statins increase LDLR expression (via ↓ hepatic cholesterol synthesis), PCSK9 inhibitors prevent LDLR degradation

Now Destroy the Distractors (Why Each Wrong Choice Matters)

A. Decreased activity of lipoprotein lipase (LPL) — Wrong

What LPL does: hydrolyzes triglycerides in chylomicrons and VLDL → releases free fatty acids to adipose/muscle

  • Requires ApoC-II (cofactor)

What you’d see instead (Type I hyperchylomicronemia):

  • Markedly ↑ triglycerides
  • Creamy supernatant in plasma
  • Recurrent pancreatitis
  • Eruptive xanthomas (small yellow papules), lipemia retinalis
  • No increased atherosclerosis risk (chylomicrons too large to enter intima)

Key mismatch here: This vignette screams LDL problem, not massive TG/pancreatitis.

B. Defective ApoE — Wrong

What ApoE does: mediates uptake of chylomicron remnants and IDL by the liver (“E for rEmnants”)

Classic condition (Type III dysbetalipoproteinemia):

  • ↑ chylomicron remnants + ↑ IDL
  • ↑ cholesterol and ↑ triglycerides
  • Palmar xanthomas (xanthoma striatum palmare) and tuberoeruptive xanthomas
  • Premature atherosclerosis and peripheral vascular disease

Key mismatch here: Type III tends to have both cholesterol and triglycerides elevated substantially, plus palmar xanthomas—whereas this vignette emphasizes tendon xanthomas and marked LDL elevation.

D. Decreased LCAT activity — Wrong

What LCAT does: esterifies free cholesterol on HDL (helps HDL “mature”)

  • Activated by ApoA-I

Associated finding (LCAT deficiency):

  • Low HDL, impaired reverse cholesterol transport
  • Corneal opacities (“fish-eye” disease variant), hemolytic anemia, proteinuria/renal disease (classical deficiency)

Key mismatch here: LCAT deficiency is an HDL/reverse transport problem, not the classic LDL-driven tendon xanthoma picture.

E. Increased production of chylomicrons — Wrong

Chylomicrons carry dietary triglycerides from the intestine to tissues.

If chylomicrons are the dominant issue (e.g., overproduction or impaired clearance), the vignette usually points to:

  • Hypertriglyceridemia
  • Postprandial lipemia
  • Pancreatitis risk when TG is very high

Key mismatch here: This patient’s phenotype is LDL excess and premature CAD, not “TG so high it causes pancreatitis.”

High-Yield Lipoprotein Metabolism Map (USMLE Essentials)

What each particle carries (think: size → density)

  • Chylomicrons: dietary triglycerides (largest, least dense)
  • VLDL: hepatic triglycerides
  • IDL: VLDL remnant
  • LDL: cholesterol to tissues (ApoB-100)
  • HDL: reverse cholesterol transport (ApoA-I)

Apolipoproteins you must know

  • ApoB-48: chylomicron assembly (intestine)
  • ApoB-100: binds LDL receptor (LDL, VLDL)
  • ApoC-II: activates LPL
  • ApoE: remnant uptake (chylomicron remnants, IDL)
  • ApoA-I: activates LCAT (HDL)

Rapid Pattern Recognition: Hyperlipoproteinemias

Type I (LPL deficiency / ApoC-II deficiency)

  • ↑ Chylomicrons → ↑ TG
  • Pancreatitis, eruptive xanthomas
  • No premature atherosclerosis

Type IIa (LDLR defect / ApoB-100 defect)

  • ↑ LDL → ↑ cholesterol
  • Tendon xanthomas, premature CAD

Type IIb (↑ VLDL + ↑ LDL)

  • ↑ TG and ↑ cholesterol
  • Premature CAD

Type III (ApoE defect)

  • ↑ IDL + remnants → ↑ TG and ↑ cholesterol
  • Palmar xanthomas, premature CAD/PVD

Type IV (↑ VLDL)

  • ↑ TG
  • Pancreatitis risk (when severe)

Test-Day Takeaways (What to Say in Your Head)

  • Tendon xanthomas + early MI = familial hypercholesterolemia → LDL receptor (or ApoB-100) problem.
  • Pancreatitis + eruptive xanthomas + sky-high TG = LPL/ApoC-II problem.
  • Palmar xanthomas + mixed high cholesterol/TG = ApoE problem.
  • Corneal clouding + low HDL = LCAT problem.
Back to all articles